The U.S. Food and Drug Administration has approved Innoviva's oral antibiotic for common sexually transmitted infection, ...

Entasis’ Nuzolvence and GSK’s Blujepa are the first antibiotic approvals in gonorrhoea in over 30 years in the US.

The U.S. health regulator on Friday approved Innoviva's oral antibiotic to treat gonorrhea, a common sexually transmitted ...

Neisseria gonorrhoeae, the microbe responsible for gonorrhoea, is developing resistance to most antibiotics, which means we ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease.

A research team from the Faculty of Engineering at The University of Hong Kong (HKU) has harnessed citywide genetic data and ...

Gonorrhoea is one of the most common sexually transmitted diseases and has grown resistant to treatments over the years. A ...

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...

This past week, I have had a lot of patients come in with classic upper respiratory complaints — cough, congestion, runny ...

Gonorrhea is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It primarily infects the mucous membranes of the genital tract but can also affect the rectum, ...

US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents: Waltham, Massachuse ...